Pharmacokinetic Drug–Drug Interactions of DA-8010 with Clarithromycin or Rifampicin: Influence of CYP2D6 Phenotype on the Extent of These Interactions
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-12
DOI: 10.2147/dddt.s592783 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Sujong Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Clarithromycin, Cytochrome P-450 CYP2D6, Rifampin. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Dong-A ST Research Institute, Yongin, Republic of Korea.
ORCID-Profile: Sujong Lee, Heejae Won, Kyung-Sang Yu, Dae Young Lee, SeungHwan Lee
Zitieren
APA
Lee, S., Won, H., Yu, K. S., Lee, D. Y., & Lee, S. (2026). Pharmacokinetic Drug–Drug Interactions of DA-8010 with Clarithromycin or Rifampicin: Influence of CYP2D6 Phenotype on the Extent of These Interactions. Drug Design, Development and Therapy, Volume 20, 1-12. https://doi.org/10.2147/dddt.s592783
Vancouver
Lee S, Won H, Yu KS, Lee DY, Lee S. Pharmacokinetic Drug–Drug Interactions of DA-8010 with Clarithromycin or Rifampicin: Influence of CYP2D6 Phenotype on the Extent of These Interactions. Drug Design, Development and Therapy. 2026;Volume 20:1-12. doi:10.2147/dddt.s592783
BibTeX
@article{Lee2026,
author = {Lee, Sujong and Won, Heejae and Yu, Kyung-Sang and Lee, Dae Young and Lee, SeungHwan},
title = {Pharmacokinetic Drug–Drug Interactions of DA-8010 with Clarithromycin or Rifampicin: Influence of CYP2D6 Phenotype on the Extent of These Interactions},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--12},
doi = {10.2147/dddt.s592783}
}
EUVIMED